Literature DB >> 30487595

The subcellular location of cyclin B1 and CDC25 associated with the formation of polyploid giant cancer cells and their clinicopathological significance.

Fei Fei1,2, Jie Qu1,2, Kai Liu3, Chunyuan Li1,2, Xinlu Wang2,4, Yuwei Li5, Shiwu Zhang6.   

Abstract

Polyploid giant cancer cells (PGCCs) are key contributors to cancer heterogeneity, and the formation of PGCCs is associated with changes in the expression of cell-cycle-related proteins. This study investigated the intracellular localization and expression level of multiple cell-cycle-related proteins in PGCCs derived from BT-549 and HEY cells. In addition, the formation of PGCCs and the clinicopathological significance of cell-cycle-related proteins in human breast and ovarian cancer were examined. The expression levels of cell-cycle-related proteins, including cyclin B1, CDC25B, CDC25C, and other cell cycle phosphoproteins, including Chk2, and Aurora-A kinase, were determined using immunostaining and western blotting both in vitro and in vivo. Migration, invasion, and proliferation in control cells, cyclin B1 knockdown cells and their PGCCs following CoCl2 treatment were compared. In addition, human breast and ovarian cancer samples were collected to determine the correlation of number of PGCCs, expression of cell-cycle-related proteins, and tumor pathologic grade and metastasis. Our results confirm that cyclin B1 was localized in the cytoplasm of PGCCs and in the nuclei of their budding daughter cells. The phosphorylated proteins Chk2 and Aurora-A kinase regulated the expression and subcellular localization of cyclin B1, CDC25B, and CDC25C. The rate of positive cytoplasmic staining of cyclin B1 and positive nuclear staining of both CDC25B and CDC25C increased with increase in tumor grade and lymph node metastasis. Cell-cycle-related proteins, including cyclin B1, CDC25B, and CDC25C play an important role in regulating the formation of PGCCs. The inhibition of cyclinB1 and CoCl2 treatment significantly promoted cell proliferation, invasion, and migration abilities. The subcellular localization of these cell-cycle-related proteins was regulated by other cell cycle phosphoproteins, and was associated with pathologic grade and metastasis of tumors in cases of human breast and ovarian cancer.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30487595     DOI: 10.1038/s41374-018-0157-x

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  20 in total

1.  Polypoidal giant cancer cells in metastatic castration-resistant prostate cancer: observations from the Michigan Legacy Tissue Program.

Authors:  Rahul Mannan; Xiaoming Wang; Pushpinder S Bawa; Daniel E Spratt; Allecia Wilson; Jeffrey Jentzen; Arul M Chinnaiyan; Zachery R Reichert; Rohit Mehra
Journal:  Med Oncol       Date:  2020-02-06       Impact factor: 3.064

Review 2.  Giants and monsters: Unexpected characters in the story of cancer recurrence.

Authors:  Shai White-Gilbertson; Christina Voelkel-Johnson
Journal:  Adv Cancer Res       Date:  2020-05-04       Impact factor: 6.242

3.  Association and clinicopathologic significance of p38MAPK-ERK-JNK-CDC25C with polyploid giant cancer cell formation.

Authors:  Kai Liu; Rui Lu; Qi Zhao; Jiaxing Du; Yuwei Li; Minying Zheng; Shiwu Zhang
Journal:  Med Oncol       Date:  2019-11-16       Impact factor: 3.064

Review 4.  Polyploid giant cancer cells: Unrecognized actuators of tumorigenesis, metastasis, and resistance.

Authors:  Sarah R Amend; Gonzalo Torga; Ke-Chih Lin; Laurie G Kostecka; Angelo de Marzo; Robert H Austin; Kenneth J Pienta
Journal:  Prostate       Date:  2019-08-02       Impact factor: 4.104

5.  Identification of novel biomarkers and small molecule drugs in human colorectal cancer by microarray and bioinformatics analysis.

Authors:  Juan Chen; Ziheng Wang; Xianjuan Shen; Xiaopeng Cui; Yuehua Guo
Journal:  Mol Genet Genomic Med       Date:  2019-05-13       Impact factor: 2.183

6.  FGFR2/STAT3 Signaling Pathway Involves in the Development of MMTV-Related Spontaneous Breast Cancer in TA2 Mice.

Authors:  Jiaxing Du; Qi Zhao; Kai Liu; Zugui Li; Fangmei Fu; Kexin Zhang; Hao Zhang; Minying Zheng; Yongjie Zhao; Shiwu Zhang
Journal:  Front Oncol       Date:  2020-05-05       Impact factor: 6.244

Review 7.  Role of cancer stem cells in the development of giant cell tumor of bone.

Authors:  Abdul Rouf War; Kai Dang; Shanfen Jiang; Zhongwei Xiao; Zhiping Miao; Tuanmin Yang; Yu Li; Airong Qian
Journal:  Cancer Cell Int       Date:  2020-04-25       Impact factor: 5.722

8.  Cancer recurrence and lethality are enabled by enhanced survival and reversible cell cycle arrest of polyaneuploid cells.

Authors:  K J Pienta; E U Hammarlund; J S Brown; S R Amend; R M Axelrod
Journal:  Proc Natl Acad Sci U S A       Date:  2021-02-16       Impact factor: 11.205

9.  ESRRA promotes gastric cancer development by regulating the CDC25C/CDK1/CyclinB1 pathway via DSN1.

Authors:  Feng-Nan Li; Qin-Yi Zhang; Ou Li; Shi-Lei Liu; Zi-Yi Yang; Li-Jia Pan; Cheng Zhao; Wei Gong; Yi-Jun Shu; Ping Dong
Journal:  Int J Biol Sci       Date:  2021-05-10       Impact factor: 6.580

10.  Different p53 genotypes regulating different phosphorylation sites and subcellular location of CDC25C associated with the formation of polyploid giant cancer cells.

Authors:  Kai Liu; Minying Zheng; Qi Zhao; Kexin Zhang; Zugui Li; Fangmei Fu; Hao Zhang; Jiaxing Du; Yuwei Li; Shiwu Zhang
Journal:  J Exp Clin Cancer Res       Date:  2020-05-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.